Title
Category IV indications for therapeutic apheresis: ASFA fourth special issue
UMMS Affiliation
Department of Medicine, Division of Transfusion Medicine
Publication Date
2007-03-23
Document Type
Article
Subjects
*Blood Component Removal; Disease; Humans; Practice Guidelines as Topic; Societies, Medical; United States
Disciplines
Hemic and Immune Systems | Other Medical Specialties
Abstract
The American Society for Apheresis (ASFA) Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice. On the basis of this review, selected diseases are assigned one of five categories (category I, II, III, IV, and P). The diseases, which were classified as category IV indications, and the rationale for such assignment are reviewed in this article. The diseases assigned to category I, II, III, and newly created category P are discussed in a separate article in this issue.
DOI of Published Version
10.1002/jca.20131
Source
J Clin Apher. 2007 Jun;22(3):176-80. Link to article on publisher's site
Journal/Book/Conference Title
Journal of clinical apheresis
Related Resources
PubMed ID
17377982
Repository Citation
Shaz BH, Linenberger ML, Bandarenko N, Winters JL, Kim HC, Marques MB, Sarode R, Schwartz J, Weinstein R, Wirk A, Szczepiorkowski ZM. (2007). Category IV indications for therapeutic apheresis: ASFA fourth special issue. Transfusion Medicine Publications and Presentations. https://doi.org/10.1002/jca.20131. Retrieved from https://escholarship.umassmed.edu/transfusion_pp/5